This programme is supported by an Independent Educational Grant from Ipsen
This programme is supported by an Independent Educational Grant from Ipsen
Merck, Novo Nordisk, Pfizer and Sandoz.
PRRT and emerging strategies in neuroendocrine tumours
Understanding the mechanism of disease of hypophosphatasia
Pediatric endocrinologists discuss patient cases and share insights on clinical practice
Maximising outcomes for patients with advanced neuroendocrine tumours